Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Iron (Ferric Carboxymaltose) in Anaemic Colorectal Cancer Surgical Patients
2009-011382-80Phase 4Completed
- Sponsor
- Nottingham University Hospitals
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ferric carboxymaltose in anaemia and colorectal cancer (CRC), sponsored by Nottingham University Hospitals. Primary endpoints: Change in immediate preoperative haemoglobin concentration and Reduction in allogeneic blood transfusion. Started May 2009; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anaemiacolorectal cancer (CRC)
Beyond the preview
Go deeper on 2009-011382-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011382-80.